3 Things to Watch at Momenta Pharmaceuticals, Inc. (MNTA)

Despite its name, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has been losing steam since the end of 2011 with revenue falling 97% in the last nine months.

Keep Reading →